INS and metabolic syndrome: Fecal microbiota transplantation (FMT), the transfer of stool from a healthy donor, is being tested in clinical trials as an adjunctive therapy to improve insulin sensitivity in metabolic syndrome and increase responsiveness to cancer immunotherapies.